Skip to main content
SER logo

SER · Serina Therapeutics, Inc.

$2.07 -0.02 (-0.96%) At close · Jul 24
Market Cap
$31.04M
Shares
15.00M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Steve Ledger $637,500
Randall Moreadith $563,200
Srini Tenjarla $527,400
Fiscal 2024
Executive Total
Steve Ledger $3,703,621
Srini Tenjarla $1,781,288
Gregory S. Curhan $1,700,413
Joanne M. Hackett $51,183
Fiscal 2023
Executive Total
Michael D. West $1,059,269
Randall Moreadith $433,880
Tacey Viegas $356,526
Nafees N. Malik $302,151
Andrea E. Park $298,556
Steve Ledger $237,500
Joanne M. Hackett $102,850
Fiscal 2022
Executive Total
Michael D. West $562,032
Randall Moreadith $362,898
Tacey Viegas $299,480
Andrea E. Park $295,289
Nafees N. Malik $282,272
Joanne M. Hackett $103,065
Fiscal 2021
Executive Total
Michael D. West $698,783
Nafees N. Malik $368,210
Andrea E. Park $365,258
Fiscal 2020
Executive Total
Michael D. West $561,032
Andrea E. Park $437,871
Nafees N. Malik $282,272
Fiscal 2019
Executive Total
Michael D. West $1,041,701
Nafees N. Malik $518,993
Hal Sternberg $329,023
Andrea E. Park $94,139
Fiscal 2018
Executive Total
Michael D. West $1,650,407
Nafees N. Malik $782,240
Hal Sternberg $296,993

Executive changes

Person Change Filed
Farrell Simon Appointed 2026-07-22
Key facts CIK 1708599 CUSIP 81751A108 13F (30d) 5 filings 5 filers Visit website Investor relations